Keywords: AD; Alzheimer's disease; Aβ; β-amyloid peptide; NFTs; neurofibrillary tangles; EOAD; early-onset AD; LOAD; late-onset AD; OMOT; One-molecule-one-target; ROS; reactive oxygen species; CDMT; Combination-drugs-multi-targets; BBB; blood brain barrier; DDT;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 2,4-D; dichlorophenoxyacetic acid; [35S]TBPS; [35S]tertiary-butylbicyclophosphorothionate; 3-NP; 3-nitropropionic acid; 4CL; 4-coumarate: CoA ligase; 4-O-MH; 4-O-methylhonokiol; 6-OHDA; 6-hydroxydopamine; 8-oxo-dG; 8-oxo-2â²-deoxyguanosine; AChE; acetylc
Keywords: Alzheimer's disease; Early-onset; Late-onset; MRI; Voxel-based morphometry; Gray matter atrophy; EOAD; LOAD;
Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease
Keywords: AD; Alzheimer disease; Aβ; β-amyloid; ADAM10; A disintegrin and metalloproteinase domain-containing protein 10/α-secretase (brain); APP; Amyloid Protein Precursor; APOE ε4; Apolipoprotein, allele epsilon4; BACE1; beta-site amyloid precursor protein cl
Integrated late onset Alzheimer's disease (LOAD) susceptibility genes: Cholesterol metabolism and trafficking perspectives
Keywords: Aβ; Amyloid-β; AD; Alzheimer's disease; ApoE; Apolipoprotein E; APP; Amyloid precursor protein; BBB; Blood brain barrier; CLU; Clusterin; CNS; Central nervous system; CSF; Cerebrospinal fluid; DMN; Default mode network; EOAD; Early onset Alzheimer's dis
Multiparametric MRI to distinguish early onset Alzheimer's disease and behavioural variant of frontotemporal dementia
Keywords: ACE-R; Addenbrooke's Cognitive Examination-revised; EOAD; early onset Alzheimer's disease; bvFTD; behavioural variant frontotemporal dementia; CSF; cerebrospinal fluid; CC; corpus callosum; DMN; default mode network; DT; diffusion tensor; GM; grey matter;
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
Keywords: Aβ; amyloid-beta; AD; Alzheimer's disease; APP; amyloid precursor protein; AS01B; adjuvant system 01B; BSA; bovine serum albumin; DMEM; Dulbecco's modified Eagle medium; DPBS; Dulbecco's Phosphate Buffered Saline; EOAD; early-onset AD; Fig.; figure; FMOs
Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer's Disease
Keywords: AD; Alzheimer's disease; APP; amyloid precursor protein; Aβ; beta-amyloid; EOAD; Early-Onset Alzheimer's Disease; FAD; familial Alzheimer's disease; MRI; Magnetic Resonance Imaging; MMSE; Mini-Mental State Examination; PS1; presenilin 1; PS2; prese
Complement receptor 1 (CR1) and Alzheimer's disease
Keywords: AD; Alzheimer's disease; Aβ; amyloid-beta; ApoE; apolipoprotein E; BBB; blood-brain barrier; CCP; complement-control proteins; CFH; complement factor H; C3; complement factor 3; CR1; complement receptor 1; CSF; cerebrospinal fluid; E-CR1; erythrocyte c
Epigenetics in neurodegeneration: A new layer of complexity
Keywords: AD; Alzheimer's disease; PD; Parkinson's disease; Aβ; amyloid-β; SN; substantia nigra; APP; amyloid precursor protein; EOAD; early-onset Alzheimer's disease; LOAD; late-onset Alzheimer's disease; SNP; several single nucleotide polymorphisms; MZ; monozyg